about
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cellsCXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.Involvement of caspase 8 and c-FLIPL in the proangiogenic effects of the tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)Neomycin inhibits angiogenin-induced angiogenesisCrystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolutionFisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivoThe synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functionsCYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growthTumour Angiogenesis and Angiogenic Inhibitors: A ReviewInhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-γ and down-regulation of VEGFR-2 expressionDown-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesisSparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cellsKnockdown of Nrf2 inhibits the angiogenesis of rat cardiac micro-vascular endothelial cells under hypoxic conditionsKallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakageAssembly of Human Umbilical Vein Endothelial Cells on Compliant HydrogelsVascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis.Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization.Xenopus Dab2 is required for embryonic angiogenesisExpression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomasPossible Roles of CC- and CXC-Chemokines in Regulating Bovine Endometrial Function during Early Pregnancy.Targeting cancer therapy.Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesisAnti-tumor activity of N-trimethyl chitosan-encapsulated camptothecin in a mouse melanoma model.Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signalingAngiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions.Effects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathway.Therapeutic angiogenesis and vasculogenesis for tissue regeneration.Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor.The Safety Evaluation of a Potent Angiogenic Activator, Synthetic Peptide (SFKLRY-NH2) for the Skin Application.Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathwayMechanism and its regulation of tumor-induced angiogenesis.Antiangiogenic activity of the lipophilic antimicrobial peptides from an endophytic bacterial strain isolated from red pepper leaf.Proangiogenic compositions of microvesicles derived from human umbilical cord mesenchymal stem cellsVascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
P2860
Q22008760-D41DD030-6C9E-4A02-942E-99180A30BB39Q24301574-2F22E29E-BF5A-4898-90E3-E57C66FC65A4Q24318416-FAB81873-85AC-454F-B23D-E7B24BFA5043Q24321282-CBFED9B0-FE60-4054-AFA2-3273EEF36166Q24324597-A9C0AFE6-BAC5-4F04-8C9D-E9DFED52FDD2Q24533185-5C59F524-94D4-435A-AAFD-69A71F93F932Q24554513-D01C84C3-6868-43DE-BD46-2D447C36F96DQ24643504-04470054-40DC-4A80-A31C-9A1A9DBD53E5Q24647068-0E90E385-2A25-48AF-90A6-8C81657F0AF9Q26798822-8D907478-4E01-42F2-8148-7FA8CDEA96EEQ27332433-637D2E10-93EF-4F4A-8529-01EC8728FC16Q28215072-6E41735F-66B7-4174-B82E-6F89A097004DQ28241644-637039A0-1B50-410F-9418-ECDFA2177386Q28535129-53A10E22-EDF3-4797-B2B8-42D24E5571F1Q28564449-390DBDFF-0DA6-4048-B890-0F67AAB536D1Q28577418-0849BEF6-F85F-4043-B9B2-625AB39CDC02Q30502349-15100ADC-D71C-4C71-B77C-3575BF073990Q30636178-C4A08A00-4C71-42FB-9303-185D79618B59Q30864689-80E33B07-352D-4B83-B91A-052BA879982BQ31146840-52F3699D-EF71-4849-830A-F39D22320F2AQ31877730-16DE0264-94C0-47A6-ACAE-4BCE375B4B74Q33266946-6E9ACE33-34A3-41CB-8C60-89C548D84049Q33274511-4FE9D7EF-D8B3-4EFC-A061-10ABF957D4F1Q33624454-B56A035C-5A4E-442B-8408-FF2C46B2CB9BQ33722407-D65447DD-BFD8-4B9F-BF9E-86B4342727AEQ33890198-13CEDCBD-9CDC-42DF-80FA-30FAD9603CB7Q33958630-054435D7-5131-45AB-BEDC-05C3B0BD3964Q34012586-58BF990D-967B-4D92-BA28-398C0C447E1AQ34101582-3DB845AB-783C-446F-A76E-693D9E9B19A3Q34327373-5BB04EE2-8F11-4B74-B692-B6F78425819FQ34341970-7930B3CB-4F6D-4C99-87FC-0C1ADDC2C01CQ34404695-10DBC943-5AC4-451F-A5B1-70BBF196CD44Q34527211-7EDAB454-8368-4A07-8C24-D867E35CC6B6Q34605475-E220EC0E-2598-4DA1-B66F-64067C4697B6Q35054204-1D933B3F-0266-4718-9650-7A6D719A5629Q35131481-276927CE-D3FC-4FD1-BB15-32E847C35BA1Q35151099-89C519AA-9AAD-469F-9078-00747E6015C3Q35188518-802CD6DD-CB3C-4ADA-9755-458C95E91D69Q35524824-E7F5D518-32D8-4416-A5B6-9FF665857C99Q35750283-F53042A1-C1D6-4AC2-8C26-CFED4B98BAE6
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Molecular mechanisms of blood vessel formation.
@en
type
label
Molecular mechanisms of blood vessel formation.
@en
prefLabel
Molecular mechanisms of blood vessel formation.
@en
P1476
Molecular mechanisms of blood vessel formation.
@en
P2093
Bussolino F
P304
P356
10.1016/S0968-0004(97)01074-8
P577
1997-07-01T00:00:00Z